In other countries
The same active substances on other registers, the same brand first.
- Auro-PazopanibCanada · 200 MG · Tablet · Auro Pharma INCSame form
- PMS-PazopanibCanada · 200 MG · Tablet · Pharmascience INCSame form
- VotrientCanada · 200 MG · Tablet · Novartis Pharmaceuticals Canada INCSame form
- Pazopanib Accord 200 MG Comprimidos Recubiertos con Película EfgSpain · 216,70 mg · comprimido recubierto con película · Accord Healthcare S.L.U.Same form
- Pazopanib Accord 400 MG Comprimidos Recubiertos con Película EfgSpain · 433,40 mg · comprimido recubierto con película · Accord Healthcare S.L.U.Same form
- Pazopanib DR. Reddys 200 MG Comprimidos Recubiertos con Pelicula EfgSpain · 216,70 mg · comprimido recubierto con película · Reddy Pharma Iberia S.A.Same form
- Pazopanib AccordItaly · Compressa rivestita con film · Accord Healthcare, S.L.U.Same form
- Pazopanib DR. Reddy'SItaly · Compressa rivestita con film · DR. Reddy'S S.R.L.Same form
- Pazopanib EgItaly · Compressa rivestita con film · Eg S.P.A.Same form
- Pazopanib Accord 200 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Accord Healthcare B.V.Same form
- Pazopanib Accord 400 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Accord Healthcare B.V.Same form
- Pazopanib CF 200 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Centrafarm B.V.Same form
- Pazopanib ADVZNew Zealand · Tab 200 mgSame form
- Pazopanib TevaNew Zealand · Tab 400 mgSame form
- Pazopanib TevaNew Zealand · Tab 200 mgSame form
- Frontient®Serbia · 400mg · film tableta · Zdravlje Ad LeskovacSame form
- Frontient®Serbia · 200mg · film tableta · Zdravlje Ad LeskovacSame form
- LiburadoneSerbia · 200mg · film tableta · Rhei Life DOOSame form
- Pazopanib-Teva FC Tablets 200 MGSingapore · 200 mg · tablet, film coated · Teva Pharmaceutical Investments Singapore Pte. LTD.Same form
- Tyroka Film-Coated Tablets 200 MGSingapore · 200mg · tablet, film coated · Lotus International Pte. LTD.Same form
- Votrient Tablet 200 mgSingapore · 200 mg · tablet, film coated · Novartis (Singapore) Pte LTDSame form
- Pazopanib HydrochlorideUnited States · 200MG BASE, 400MG BASE · tablet · Teva Pharms INCSame form
- VotrientUnited States · 200MG BASE, 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · NovartisSame form
- cloridrato de pazopanibeBrazil · Ranbaxy Farmacêutica LtdaSame substance
- cloridrato de pazopanibeBrazil · Eurofarma Laboratorios S.A.Same substance
- PazovantBrazil · Sun Farmacêutica do Brasil LtdaSame substance
- VotrientEuropean Union · Novartis Europharm LimitedSame substance
- VotrientSaudi Arabia · GlaxoSame substance
- Alvopanib Film-Coated Tablets 200mgTaiwan · 膜衣錠 · 美時化學製藥股份有限公司Same substance
Packs
| Pack | Code | Status |
|---|---|---|
| 30 tableta u blisteru, u kutiji | HR-H-259497647-01 | stavljeno u promet |
| 60 tableta u blisteru, u kutiji | HR-H-259497647-02 | nije stavljeno u promet |
| 90 tableta u blisteru, u kutiji | HR-H-259497647-03 | nije stavljeno u promet |
| 60 tableta (2 pakiranja sa po 30 tableta u blisteru), u kutiji | HR-H-259497647-04 | nije stavljeno u promet |
| 90 tableta (3 pakiranja sa po 30 tableta u blisteru), u kutiji | HR-H-259497647-05 | nije stavljeno u promet |
| 30 tableta u bočici, u kutiji | HR-H-259497647-06 | nije stavljeno u promet |
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Pazopanib
- Dosage form
- Filmom obložena tableta
- Register
- Croatia (HALMED)
- Status
- Marketed
- Status in the register
- stavljeno u promet; nema nestašice
- Authorised
- 3 Jan 2022
- Registration
- HR-H-259497647
- Marketing authorisation holder
- Teva B.V., Swensweg 5, Haarlem, Nizozemska
- Manufacturer
- PharOS MT Ltd, Birzebbugia, Malta<br/>Remedica Ltd., Limassol, Cipar
- ATC code
- L01EX03
- Procedure
- National, MRP or DCP
- Supply
- na recept; u ljekarni



